收藏切换
Pharmacokinetics Study of Polymyxin B in Patients with Sepsis
收藏切换
PDF
Jun ZHANGa, Lin ZHOUa, Tianyuan ZHENGa, Yonggang LUOb, *, Zhi SUNa, *
Chinese Pharmaceutical Journal | 2024, 59(15) : 1424 - 1428
Less
收藏切换
Chinese Pharmaceutical Journal | 2024, 59(15): 1424-1428
Pharmacokinetics Study of Polymyxin B in Patients with Sepsis
Full
Jun ZHANGa, Lin ZHOUa, Tianyuan ZHENGa, Yonggang LUOb, *, Zhi SUNa, *
Affiliations
  • a. Department of Pharmacy, b. Department of Neurosurgery Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China
Published: 2024-08-08 doi: 10.11669/cpj.2024.15.009
Outline
收藏切换

OBJECTIVE To study the pharmacokinetics of polymyxin B (PB) in sepsis patients and to provide evidence for its rational clinical use. METHODS Sepsis patients were given intravenous PB, every 12 h (q12 h), 4 consecutive doses. Blood samples were collected before each dose and 0.5, 1, 2, 3, 6, 9, 12 h after the fifth dose. The plasma concentrations of PB were determined by UHPLC-MS/MS method. The main pharmacokinetic parameters were calculated by non-compartment model, and a limited sampling model was established with sparse blood concentration data points. RESULTS A total of 18 patients were included. The main pharmacokinetic parameters of PB were as follows: area under the concentration-time curve for the 24 h exposure after the fifth dose(AUC0-24 h) was (63.33±30.88) mg·h·L-1, plasma concentrations prior to the fifth dose(ρ0) was (2.01±1.54) mg·L-1, post the fifth dose peak plasma concentration(ρmax) was (6.90±4.22) mg·L-1, plasma concentrations of 12 h after the fifth dose(ρ12) was (1.64±1.04) mg·L-1, average steady-state plasma concentration(ρss,av) was (2.64±1.29) mg·L-1, trough concentrations after the first, second and third doses were (3.35±2.50) (2.74±1.60) and (1.76±1.10) mg·L-1, respectively. The recommended two-point regression equation is AUC0-12 h=2.08+1.22ρ1+9.41ρ6. CONCLUSIONS There are individual variabilities in the pharmacokinetic parameters of PB in patients with sepsis. The loading dose of the first dose can reach the steady-state concentration as soon as possible, and the PB concentration point 1,6 h after administration can be used to estimate AUC0-24 h. It is suggested to monitor PB-AUC0-24 h to guide the adjustment of PB dosage in adult patients with sepsis.

polymyxin B  /  sepsis  /  pharmacokinetic  /  limited sampling strategy  /  UHPLC-MS/MS
Jun ZHANG, Lin ZHOU, Tianyuan ZHENG, Yonggang LUO, Zhi SUN. Pharmacokinetics Study of Polymyxin B in Patients with Sepsis[J]. Chinese Pharmaceutical Journal, 2024 , 59 (15) : 1424 -1428 . DOI: 10.11669/cpj.2024.15.009
Year 2024 volume 59 Issue 15
PDF
71
31
Cite this Article
BibTeX
Article Info
doi: 10.11669/cpj.2024.15.009
  • Receive Date:2023-09-24
  • Online Date:2026-01-14
  • Published:2024-08-08
Article Data
Affiliations
History
  • Received:2023-09-24
Funding
Affiliations
    a. Department of Pharmacy, b. Department of Neurosurgery Intensive Care Unit, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China
References
Share
https://castjournals.cast.org.cn/joweb/zgyxzz/EN/10.11669/cpj.2024.15.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT